603387 Getein Biotech,Inc
- 9.88
- +0.04+0.41%
Getein Biotech,Inc News
Getein Biotech,Inc: 2023 Accounting Firm Performance Assessment Report
Getein Biotech,Inc: Special note by the board of directors on matters covered in the 2023 internal control audit report with unqualified opinions on the highlighted areas
Getein Biotech,Inc: Announcement on the use of own idle funds for investment and financial management
Getein Biotech,Inc: Announcement on the implementation of daily related transactions in 2023 and the forecast for daily related transactions in 2024
Getein Biotech,Inc: Announcement of Resolutions of the Second Meeting of the Fourth Board of Directors
Getein Biotech,Inc: Special report of the board of directors on the self-inspection of the independence of independent directors
Getein Biotech,Inc: Announcement of the 2023 Annual Profit Distribution Plan
Getein Biotech,Inc: Notice on the holding of the 2023 Annual General Meeting of Shareholders
Getein Biotech,Inc: Announcement of Resolutions of the Second Meeting of the Fourth Board of Supervisors
Getein Biotech,Inc: 2024 First Quarter Report
Getein Biotech,Inc: Notice on changes in accounting policies
Getein Biotech,Inc: Announcement on the renewal of the 2024 annual audit accounting firm
Getein Biotech,Inc: Announcement on the Company and its wholly-owned and holding subsidiaries applying for comprehensive credit lines from banks
Getein Biotech,Inc: Announcement on holding the 2023 Annual Results Briefing
Getein Biotech,Inc: 2023 Annual Report Summary
Getein Biotech,Inc: 2023 ANNUAL REPORT
Getein Biotech,Inc: 2023 Annual Audit Report
Getein Biotech,Inc: Special explanation on the use of non-operating capital and other related financial transactions in 2023 by Geidou Biotech
Getein Biotech,Inc: 2023 Independent Director Debriefing Report (Luo Jing)
Getein Biotech,Inc: Special note by the board of directors on matters covered in the 2023 unqualified opinion audit report with highlighted sections
Analysis
Price Target
No Data
